Currently, only about 20% of all cancer patients will actually benefit from costly immunotherapy. New research can now determine which ones are in that category, simply by analyzing previously unseen changes in patterns in CT scans taken when the lung cancer is first diagnosed compared to scans taken after the first 2-3 cycles of immunotherapy treatment.
from Top Technology News -- ScienceDaily https://ift.tt/3398jOA
Saturday, 23 November 2019
Using artificial intelligence to determine whether immunotherapy is working
About Unknown
Magazine Power Theme is officially developed by Templatezy Team. We published High quality Blogger Templates with Awesome Design for blogspot lovers.The very first Blogger Templates Company where you will find Responsive Design Templates.
Subscribe to:
Post Comments (Atom)
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean. 
SOCIALIZE IT →